まとめ
素因子XIIは,prekallikreinをkallikreinに活性化することによって,血液凝固,線維分解,キニン生成を開始する. この酵素カスケードは,関連する生理学的イベントで,フィブリン,プラズミン,またはブラジキニンの形成につながります.
科学分野:
- バイオケミストリー バイオケミストリー
- 血液学 ヘマトロジ
- 生理学 生理学とは
背景:
- プラズマプレカリクリインの活性化は,キニンの生成と凝固に不可欠です.
- 因子XII (FXII) は,凝固の固有の経路の重要なイニシアターです.
- 高分子量キニノゲン (HMWK) とカオリンは,FXII媒介活性化における重要な共因子である.
研究 の 目的:
- 単一鎖因子XIIによるプラズマプレカリクレインの活性化メカニズムを調査する.
- この活性化過程におけるHMWKとカオリンの役割を明らかにする.
- FXIIが特定の生理学的カスケードをどのように誘発するかを理解する.
主な方法:
- 精製された単鎖因子XIIを用いたプラズマプレカリクレインの活性化を研究した.
- 高分子量キニノゲンとカオリンの存在下での反応を調査した.
- その結果生じる酵素のカスケードと製品形成を分析した.
主要な成果:
- 素因子XIIは,カオリンの存在で,プレカルリクレインをカルリクレインに効果的に活性化します.
- この活性化により,固有の酵素カスケードが始まります.
- このプロセスは,フィブリン,プラズミン,またはブラジキニンの生成につながります.
結論:
- 単鎖因子XIIは,カオリンとHMWKとともに,血液凝固,線維解離,キニン生成を起こす.
- プレカルリクレーンのカリクレーンへの変換は,これらの相互接続された経路における中心的なステップです.
- FXIIは,これらの3つの重要な生理学的出来事を結びつける重要な酵素として機能します.
さらに関連する動画
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
07:13Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
